Anpac Bio Medical Financials

Anpac Bio Stock Summary

Anpac Bio competes with Anebulo Pharmaceuticals, Aerovate Therapeutics, Acrivon Therapeutics,, Opthea, and AN2 Therapeutics. AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the Peoples Republic of China. The company was incorporated in 2010 and is headquartered in Lishui, the Peoples Republic of China. Anpac Bio-Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people.

Anpac Bio Key Financial Ratios

Anpac Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Anpac Bio's current stock value. Our valuation model uses many indicators to compare Anpac Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Anpac Bio competition to find correlations between indicators driving Anpac Bio's intrinsic value. More Info.Anpac Bio Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Anpac Bio's earnings, one of the primary drivers of an investment's value.

Anpac Bio Market Pulse

Along with financial statement analysis, the daily predictive indicators of Anpac Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Anpac Bio Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Anpac Bio Medical based on widely used predictive technical indicators. In general, we focus on analyzing Anpac Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Anpac Bio's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

If you are still planning to invest in Anpac Bio Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anpac Bio's history and understand the potential risks before investing.